Protein Design Labs Posts 74% Revenue Jump in Q3; Expects Breakeven in End 01 | GenomeWeb

NEW YORK, Nov. 2 - Protein Design Labs has reported a narrower-than-expected third-quarter loss on a 74 percent spike in revenues, the company said.

The company, which develops humanized monoclonal antibodies, posted a net loss for the period ended Sept. 30 of $1.8 million, or 2 cents per basic and diluted share, compared with net loss of $5.1 million, or 6 cents per share, in 2000.

A consensus estimate of Wall Street analysts polled by Thomson Financial/First Call expected a loss of 5 cents per share.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."